postprandial

1-Deoxynojirimycin (Moranoline) 是一种口服具有活性的 α-葡萄糖苷酶抑制剂。它具有降血糖、减肥和抗病毒的活性。它抑制餐后血糖，预防糖尿病。

1-Deoxynojirimycin hydrochloride (Moranoline) 是一种口服有效的 α-葡萄糖苷酶抑制剂，具有降血糖、减肥和抗病毒的作用，可抑制餐后血糖，预防糖尿病。

ARRY-403 是一种新型葡萄糖激酶激活剂，可降低 2 型糖尿病患者的空腹和餐后血糖，可用于治疗糖尿病。

Casein 是一种具有多种作用的牛奶蛋白，参与新型药物递送系统，通过其胃内凝血特性以不同的方式影响餐后氨基酸递送。

Mizagliflozin 是口服有效的、选择性的 SGLT1抑制剂，对人 SGLT1 的 Ki 值为 27 nM。Mizagliflozin 对 SGLT1 的选择性是 SGLT2的303 倍。Mizagliflozin 是抗糖尿病药物，可以改善餐后血糖波动并有可能有改善慢性便秘的潜力。

Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose conce

2,7 -Phloroglucinol-6,6'-bieckol 作为一种有效的口服α-amylase α-glucosidase双重抑制剂，其IC50值分别为6.94 μM和23.35 μM。该化合物能有效缓解糖尿病小鼠餐后高血糖症状，常用于糖尿病的相关研究。

AZD-6370 is a glucokinase activator. AZD-6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food. AZD-6370 do not affect the central counterregulatory response to hypoglycemia

Massarigenin C is a fungal metabolite that has been found inM. flavoroseaand has enzyme inhibitory activities.1,2Massarigenin C inhibits neuraminidasein vitro(IC50= 4.15 μM).2It is also an inhibitor of yeast α-glucosidase (IC50= 1.25 mM).1It reduces the postprandial peak in blood glucose levels in an oral sucrose tolerance test in normo- and hyperglycemic mice when administered at doses of 3.2, 10, and 31.6 mg kg.

Enprostil is a synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has efficient and safe in the therapy of gastroduodenal ulcers.

50F10 is a stabilizer for the active LPL dimer. It can act by preventing angptl4- and heat-induced inactivation of LPL and reducing postprandial triglyceride levels.

D-(+)-Sorbose，一种 D-Sorbose 的活性对映异构体，可抑制双糖酶活性并对大鼠餐后血糖和胰岛素水平有抑制作用。D-Sorbose 作为甜味剂有助于预防相关疾病，如 2 型糖尿病。

Trilobatin (P-Phlorizin) 是源自Lithocarpus polystachyusRehd 的甜味剂，是一种HIV-1抑制剂，靶向 Gp41 包膜蛋白，具有神经保护作用。它还是SGLT1 2抑制剂，可选择性诱导人肝母细胞瘤细胞增殖。

Cetagliptin 是一种口服有效的二肽基肽酶 4 (dipeptidyl peptidase 4，DPP-4) 和 CYP2D6 抑制剂（IC50 为 6 µM），同时也是 P-糖蛋白 (P-glycoprotein) 的底物。Cetagliptin 通过减少 GLP-1 的降解作用维持餐后血糖水平，被用于 2 型糖尿病的研究。

WB403 is a TGR5 activator. WB403 significantly decreases fasting blood glucose, postprandial blood glucose and HbA1c, improves glucose tolerance in type 2 diabetic mice. WB403 increases pancreatic β-cells and restores the normal distribution pattern of α-

(+ -)- Adomeglivant, also known as LY2409021, is a potent and selective glucagon receptor antagonist. LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Blockade of glucagon signalling in patients with type 2 diabetes is well tolerated and results in substantial reduction of fasting and postprandial glucose with minimal hypoglycaemia, but with reversible increases in aminotransferases. Inhibition of glucagon signalling by LY2409021 is a promising potential treatment for patients with type 2 diabetes and should be evaluated in longer clinical trials to better evaluate benefits and risks.

AZD7687 is a potent and selective DGAT1 inhibitor with an IC50 value of 80 nM (hDGAT1). IC50 value: 80 nM [1] Target: DGAT1 in vitro: Plasma AZD7687 exposure was measured repeatedly. AZD7687 markedly reduced postprandial TAG excursion with a steep concent

GIP (1-30) amide, human acetate 为葡萄糖依赖性促胰岛素多肽（GIP）的片段，作为一种肠降血糖素激素，它能在10^-9至10^-6M的剂量范围内，依赖剂量地促进胰岛素的分泌，并有效减缓餐后血糖波动。

Resinacein L 是一种 α-葡萄糖苷酶 (α-glucosidase) 抑制剂，其 IC50 为 0.635 mM。Resinacein L 可通过减缓碳水化合物的消化和吸收来降低餐后血糖。

α-glucosidase PTP1B-IN-1（化合物8a）作为一种抑制剂，对α-glucosidase和PTP1B展示了显著的抑制效果，其IC50值分别是66.3 μM和47.0 μM。此化合物同样对α-amylase具有较强的抑制能力，其IC50值为30.62 μM。α-glucosidase PTP1B-IN-1能够有效结合到α-glucosidase和PTP1B的活性位点，并且显示出降低餐后血糖的潜在能力，这表明其在2型糖尿病治疗中的应用前景。

GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions.

Bamadutide (SAR425899)是一种高效的GLP-1 GIP受体激动剂，主要通过增强β细胞功能和降低葡萄糖吸收速率，从而改善餐后血糖控制。该化合物适用于2型糖尿病的研究。

Stevisalioside A (Compound 2)，一种从甜叶菊根提取的化合物，展现出抗糖尿病的口服活性。该化合物有效抑制PTP1B，IC50为526.8 μM，并能降低Stevisalioside A引起的高血糖小鼠血糖水平，改善餐后血糖峰值及口服葡萄糖和胰岛素耐量测试结果。

Amylin, amide, human是一种由37个氨基酸组成的多肽激素，与胰岛素共分泌，参与调节餐后血糖水平,通过抑制胰高血糖素分泌、延缓胃排空等方式降低血糖。DAP Amylin在溶液中不稳定，易聚集形成淀粉样纤维，与2型糖尿病的胰岛β细胞损伤密切相关。